Genentech Company Updates |

Company Updates

  • From corporate giving to foundation grants and employee volunteerism, our approach to #GivingBack is leveraging our resources to drive real and lasting change in our communities. Read more about the ways we give back. #GivesBackWeek

  • We’re excited to announce that our own Sandra Milan, Senior Group Director Oncology Project Team Leaders, was just named on INvolve’s EMpower 50 Ethnic Minority Future Leaders List. This designation honors role models who are making a significant contribution to ethnic minority #diversity and inclusion at work. Learn more about Sandra and the other honorees. #EMRoleModels19

  • Recently in MIT Technology Review, our work on personalized cancer vaccines was named on their list of 10 Breakthrough Technologies of 2019. Read why Bill Gates chose to include our research on harnessing the body's natural defenses to target tumors below.

    10 Breakthrough Technologies 2019, curated by Bill Gates

    I was honored when MIT Technology Review invited me to be the first guest curator of its 10 Breakthrough Technologies. Narrowing down the list was difficult. I wanted to choose things that not only will create headlines in 2019 but captured this moment in technological history-which got me thinking about how innovation has evolved over time.

  • A diverse and inclusive workplace is critical to our mission of helping people with serious diseases. We’re honored to be named a Human Rights Campaign Best Place to Work for LGBTQ Equality. Read more about the 2019 Corporate Equality Index (CEI) below.

    HRC's 2019 Corporate Equality Index | Human Rights Campaign

    HRC's CEI is the national benchmarking tool on corporate policies and practices pertinent to LGBTQ employees.

  • Earlier this month we were thrilled to welcome Alexander Hardy as our Chief Executive Officer! Alexander is focused on continuing to foster an environment where scientific innovation can thrive and ensuring patients with serious diseases have access to the breakthrough medicines they need. Learn more about the exciting work we're doing and our commitment to science, patients, and our people by following the link below.


    Breakthrough science. One moment, one day, one person at a time.

  • We're grateful to our employees for naming us to Great Place to Work and Fortune's list of 100 Best Companies for more than two decades! Read the full list below.

    100 Best Companies to Work For 2019

    Our 100 Best Companies to Work For 2019 list, in partnership with Great Place to Work, features Salesforce, T-Mobile, Dropbox, and more.

  • We're inspired by the many talented people working here to do now what patients need next. Meet some of the faces who motivate us each and every day!

    Genentech: Topics | Our People

    These are the stories - of obstacles and opportunities - that celebrate the people who work here.

  • Our ability to bring transformative medicines to patients depends on the positive experience, engagement, and resilience of everyone who works here. Learn more from Nancy Vitale, Senior Vice President, Human Resources, about our holistic approach to wellbeing at work.

    Experiments In Wellbeing

    From bathtubs in ancient Greece to falling apples, the history of science is full of storied "Eureka" moments. Of course, the reality behind these big breakthroughs is rarely so instantaneous: The process of scientific discovery is more often long, intense and punctuated by failure. Scientists might go decades or even a lifetime without achieving their goals.

  • We're partnering with Adaptive Biotechnologies—a pioneer in immunosequencing—to develop a type of cellular therapy for cancer that targets #neoantigens. Read more about the science behind our collaboration in "A New Age for Neoantigens."

    A New Age for Neoantigens

    Progress in medicine requires going beyond what's known in order to reveal new fundamental truths about human biology. Today, no area encapsulates this search better than cancer immunotherapy. "The rate of discovery in this space is shocking," says Ira Mellman, Ph.D., Vice President, Cancer Immunology.

  • In case you missed it, our very own Sara Kenkare-Mitra, SVP of Development Sciences was named one of FiercePharma's Fiercest Women in Life Sciences for 2018! This recognition is the product of her trailblazing work in pharmacology and her pursuit of a lifelong dream to deliver medicines to those who need them most. Read more about Sara below.

    Dreams from Mumbai

    As one the first local physicians in his state to be trained in Western medicine, her grandfather had seen it all. He was a community doctor who, as Sara puts it, "did very little for his own pockets."

Work at Genentech? Share Your Experiences

  • Star
  • Star
  • Star
  • Star
  • Star
Click to Rate